Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent process for Dabigatran intermediate offering high purity and scalable manufacturing without column chromatography for reliable supply chain.
Patent CN114716382B details continuous flow synthesis for Ensitrelvir intermediates ensuring high purity and scalable production for reliable pharmaceutical intermediate supplier partnerships.
Novel catalytic method for 3,3'-bisindole synthesis offers significant cost reduction and scalable manufacturing capabilities for the global pharmaceutical intermediates supply chain.
Novel palladium-catalyzed method for Epristeride ensures high purity and scalable production for pharmaceutical supply chains reducing costs significantly and improving safety
Novel solvent system ensures high purity Atazanavir Sulfate. Reduced complexity and cost for pharmaceutical supply chains.
Novel preparation method avoids pungent reagents. High yield, short route. Cost-effective manufacturing for global supply chains.
Patent CN114075143A reveals a one-pot synthesis for Olaparib intermediates, eliminating unstable phosphorus ylide isolation to ensure high purity and cost-effective manufacturing.
Patent CN107382874A details high-yield synthesis of chiral NHC salts. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Novel crystallization method achieves 99.99% purity for Trelagliptin Succinate, offering significant cost and supply chain advantages for global pharma manufacturers.
Novel iodination-amination route for Larotrectinib intermediate. Enhances purity above 98.5 percent and scalability. Reliable supply chain partner for pharmaceutical manufacturing.
Novel chemo-enzymatic route for Eluxadoline intermediate. High yield, scalable, cost-effective pharmaceutical intermediates manufacturing for global supply chains.
Patent CN110117254B reveals a streamlined 3-step route for Cabozantinib, replacing hazardous nitration with efficient one-pot reduction and copper-catalyzed decarboxylation for superior supply chain stability.
Novel C2 symmetric tetrahydropyrimidine synthesis. High yield, scalable route for asymmetric catalysis intermediates.
Patent CN110511159A offers high-purity Benserazide Hydrochloride synthesis avoiding DMF solvents for cost-effective pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN109182298B details engineered lipase mutants for high-efficiency resolution of moxifloxacin intermediates, offering significant cost reduction and supply chain reliability.
Patent CN115894326B reveals Rhodium-catalyzed synthesis for high-purity aminoindole derivatives. Safe vinylene carbonate route offers substantial supply chain and cost advantages.
Electrochemical synthesis patent CN117660991A enables high-purity pharmaceutical intermediates with reduced costs and enhanced supply chain reliability for global buyers.
Novel Ru-BINAP catalyzed route for (R)-5'-methoxylaudanosine. High purity >99.98% ee, non-genotoxic process, scalable for Mivacurium Chloride production.
Patent CN101693738B reveals a green solid-phase oxidation method for Terlipressin, offering higher yields and reduced waste for reliable API manufacturing.
Advanced Sharpless epoxidation process for (S)-beta-hydroxy-gamma-butyrolactone. Delivers high enantiomeric excess and cost-effective supply chain solutions for pharmaceutical manufacturing.